First Opinion Podcast Patrick Skerrett Listen: Pharma companies market their drugs to young adults — so why don’t they include them in clinical trials?
First Opinion Jennifer Rubin Grandis It’s all in the details: start-up packages and ongoing gender bias in academic medicine
Pharmalot Ed Silverman Clinical trial sites face challenges in diversifying personnel and participants, study finds
Health Megan Thielking How to rebrand a research study? For one project, Instagram influencers and a dash of wit go a long way
Opinions+ Nick Stephens How to create successful leadership teams for cell and gene therapy companies
Biotech Matthew Herper Tempus, a well-funded company run by a Groupon billionaire, wants to get patients into clinical trials
First Opinion Jennifer Dent Patients of African descent are being denied the benefits of cancer breakthroughs. We’re changing that
Health Ike Swetlitz African-Americans are disproportionately enrolled in studies that don’t require informed consent
Special Report Caroline Chen and Riley Wong — ProPublica Denied ‘life-extending opportunities’: Black patients are being left out of clinical trials amid wave of new cancer therapies
Business Rebecca Robbins With big-name backing, a startup launches to match cancer patients with clinical trials
Biotech Rebecca Robbins Stock, sky-high salaries and a $10,000 watch: Startups desperately compete for top experts in gene and cell therapy
First Opinion Mason Marks and Tiffany Li DNA donors must demand stronger protection for genetic privacy
Biotech Jonathan Saltzman — Boston Globe The growth of Mass. biotechs is outpacing the number of qualified workers
First Opinion Melissa Burstein More female leaders will help drive innovation in the medtech and biotech industries
First Opinion Jonathan Kimmelman and Alex John London Cancer centers sell out science when they advertise clinical trials as treatment
Health Rebecca Robbins How a society gala was used to sell young-blood transfusions to baby boomers desperate to cheat death
First Opinion Andy Coravos and Sofia Warner Blockchains and health care: promising and moving quickly, though no silver bullet